Application of the ADVIA cerebrospinal fluid assay to count residual red blood cells in blood components

Vox Sanguinis

Volumn 103, Issue 3, 2012, Pages 186-193

  Culibrk, B ^a   Stone, E ^a   Levin, E ^a   Weiss, S ^b   Serrano, K ^a   Devine, D V ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

Automated haematology analysers; Plasma; Platelet; Residual red blood cells; Transfusion

Indexed keywords

REAGENT; THROMBOCYTE CONCENTRATE;

ACCURACY; ADVIA 120 CEREBROSPINAL FLUID ASSAY; APHERESIS; ARTICLE; ASSAY; BLOOD ANALYSIS; BLOOD COMPONENT; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DILUTION; ERYTHROCYTE COUNT; GOLD STANDARD; HUMAN; HUMAN TISSUE; INCUBATION TIME; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; NAGEOTTE CHAMBER COUNTING; PRIORITY JOURNAL; THROMBOCYTE;

AUTOMATION; BLOOD CELLS; BLOOD COMPONENT TRANSFUSION; CELL COUNT; CEREBROSPINAL FLUID; ERYTHROCYTE COUNT; ERYTHROCYTES; HUMANS;

EID: 84866462225     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2012.01601.x     Document Type: Article

References (20)

1. Santana JM, Dumont LJ: A flow cytometric method for detection and enumeration of low-level, residual red blood cells in platelets and mononuclear cell products. Transfusion 2006; 46:966-972
2. Lozano M, Cid J: The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev 2003; 17:57-68
3. Atoyebi W, Mundy N, Croxton T, et al.: Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? Br J Haematol 2000; 111:980-983
4. Cid J, Carbasse G, Pereira A, et al.: Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients. Transfusion 2011; 51:1163-1169
5. Cid J, Lozano M: Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipients. Transfusion 2005; 45:453-454
6. Cid J, Ortin X, Elies E, et al.: Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion 2002; 42:173-176
7. Frohn C, Dumbgen L, Brand JM, et al.: Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion. 2003; 43:893-898
8. Haspel RL, Walsh L, Sloan SR: Platelet transfusion in an infant leading to formation of anti-D: implications for immunoprophylaxis. Transfusion 2004; 44:747-749
9. Price TH: Standards for Blood Banks and Transfusion Services, 25th edn. Bethesda, MD, AABB, 2008
10. Council of Europe: Guide to the Preparation, Use and Quality Assurance of Blood Components, 11th edn. Strasbourg Cedex, France, Council of Europe Publishing, 2005
11. Krailadsiri P, Seghatchian J: Residual red cell and platelet content in WBC-reduced plasma measured by a novel flow cytometric method. Transfus Apher Sci 2001; 24:279-286
12. Pichler J, Printz D, Scharner D, et al.: Improved flow cytometric method to enumerate residual cells: minimal linear detection limits for platelets, erythrocytes, and leukocytes. Cytometry 2002; 50:231-237
13. Canadian Blood Services: Canadian Blood Services Visual Assessment Guide. Canadian Blood Services, 2009. http://www.transfusionmedicine.ca/sites/transfusionmedicine/files/PDF/VAG_en.pdf (accessed 18 October 2011).
14. Mahieu S, Vertessen F, Van der Planken M: Evaluation of ADVIA 120 CSF assay (Bayer) vs. chamber counting of cerebrospinal fluid specimens. Clin Lab Haematol 2004; 26:195-199
15. Siemens: ADVIA® 120 Cerebrospinal Fluid (CSF) Assay - Customer Bulletin (067D0014-01 Rev. A, 2002-10). 2002.
16. Levin E, Culibrk B, Gyongyossy-Issa MI, et al.: Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Transfusion 2008; 48:2331-2337
17. Passing H, Bablok W: A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I. Clin Chem Lab Med 1983; 21:709-720
18. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310
19. Menitove JE: Immunoprophylaxis for D- patients receiving platelet transfusions from D+ donors? Transfusion 2002; 42:136-138
20. Goldfinger D, McGinniss MH: Rh-incompatible platelet transfusions--risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971; 284:942-944